"Life-Steps" for PrEP Adherence: Demonstration of a CBT-Based Intervention to Increase Adherence to Preexposure Prophylaxis (PrEP) Medication Among Sexual-Minority Men at High Risk for HIV Acquisition
- PMID: 28392673
- PMCID: PMC5381825
- DOI: 10.1016/j.cbpra.2016.02.004
"Life-Steps" for PrEP Adherence: Demonstration of a CBT-Based Intervention to Increase Adherence to Preexposure Prophylaxis (PrEP) Medication Among Sexual-Minority Men at High Risk for HIV Acquisition
Abstract
One dramatic advance in human immunodeficiency virus (HIV) prevention efforts has been the prescription of medications typically used for HIV treatment as prophylaxis against acquiring HIV. As a preventative agent, this practice is referred to as "preexposure prophylaxis" (PrEP). The U.S. Federal Drug Administration approved daily PrEP for adults at risk for HIV who do not consistently use condoms during sex with HIV-infected or unknown-status partners. In this paper, we describe a cognitive-behavioral therapy (CBT) PrEP adherence intervention developed for use in high-risk sexual-minority men in the United States, adapted from "Life-Steps," an evidence-based CBT intervention to promote adherence to HIV treatment. Modules include creating a PrEP dosing schedule, adhering to daily PrEP, problem solving barriers to adherence, and sexual risk-reduction techniques. Supplemented with practical video vignettes, this novel intervention may help to enhance the clinical practice of health care providers in outpatient settings to increase PrEP adherence in sexual-minority men.
Keywords: CBT; HIV; MSM; PrEP; medication adherence.
References
-
- Anderson PL, Glidden DV, Liu A, Buchbinder S, Lama JR, Guanira JV, iPrex Study Team Emtricitabinetenofovir concentrations and pre-exposure prophylaxis efficacy in men who have sex with men. Science Translational Medicine. 2012;4(151):151ra125. http://dx.doi.org/10.1126/scitranslmed.3004006. - DOI - PMC - PubMed
-
- Baeten JM, Donnell D, Ndase P, Mugo NR, Campell JD, Wangisi J, Partners PrEP Study Team Antiretroviral prophylaxis for HIV prevention among heterosexual men and women. New England Journal of Medicine. 2012;367(5):399–410. http://dx.doi.org/ 10.1056/NEJMoa1108524. - DOI - PMC - PubMed
-
- Baeten JM, Haberer JE, Liu AY, Sista N. Preexposure prophylaxis for HIV prevention: Where have we been and where are we going? Journal of Acquired Immune Deficiency Syndromes. 2013;63(2):S122–S129. http://dx.doi.org/10.1097/QAI.0b013e3182986f69. - DOI - PMC - PubMed
-
- Binford MC, Kahana SY, Altice FL. A systematic review of antiretroviral adherence interventions for HIV-infected people who use drugs. Current HIV/AIDS Reports. 2012;9(4):287–312. http://dx.doi.org/10.1007/s11904-012-0134-8. - DOI - PMC - PubMed
-
- Blashill AJ, Perry N, Safren SA. Mental health: A focus on stress, coping, and mental illness as it relates to treatment retention, adherence, and other health outcomes. Current HIV/AIDS Reports. 2011;8(4):215–222. http://dx.doi.org/10.1007/s11904-011-0089-1. - DOI - PMC - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous